Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. | BMC Med Genomics | 2022 | 35468838 | PubTator, text mining | PubMed |
| Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells. | J Immunol Res | 2022 | 35465350 | PubTator, text mining | PubMed |
| The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. | Front Immunol | 2022 | 35464489 | PubTator, text mining | PubMed |
| Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies. | Cells | 2022 | 35456007 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Kaposi Sarcoma Development. | Cancers (Basel) | 2022 | 35454776 | PubTator, text mining | PubMed |
| The Entanglement between Mitochondrial DNA and Tumor Metastasis. | Cancers (Basel) | 2022 | 35454769 | PubTator, text mining | PubMed |
| Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer. | J Immunol Res | 2022 | 35450395 | PubTator, text mining | PubMed |
| Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. | Cell | 2022 | 35447071 | PubTator, text mining | PubMed |
| Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma. | Pigment Cell Melanoma Res | 2022 | 35445563 | PubTator, text mining | PubMed |
| Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7. | Front Immunol | 2022 | 35444636 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas. | Sci Rep | 2022 | 35440701 | PubTator, text mining | PubMed |
| Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma. | Cancer Immunol Res | 2022 | 35439317 | PubTator, text mining | PubMed |
| Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis. | Am J Physiol Gastrointest Liver Physiol | 2022 | 35437997 | PubTator, text mining | PubMed |
| Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. | Transl Oncol | 2022 | 35413499 | PubTator, text mining | PubMed |
| CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. | Oxid Med Cell Longev | 2022 | 35401923 | PubTator, text mining | PubMed |
| LncRNA HCP5 enhances the proliferation and migration of cervical cancer via miR-216a-5p/CDC42 axis. | J Cancer | 2022 | 35399723 | PubTator, text mining | PubMed |
| [Expression Level of SOCS3 in Acute Lymphoblastic Leukemia Cells Affects the Cytotoxicity of NK Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 | 35395970 | PubTator, text mining | PubMed |
| CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. | Nat Commun | 2022 | 35393416 | PubTator, text mining | PubMed |
| Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms. | Front Immunol | 2022 | 35392097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=39